Skip to content

Influence of the COvid-19 Epidemic on STRESS

The COVISTRESS Study: Influence of the COvid-19 Epidemic on STRESS

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04308187
Acronym
COVISTRESS
Enrollment
50000
Registered
2020-03-13
Start date
2020-03-11
Completion date
2022-03-31
Last updated
2020-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress, Psychological

Keywords

Stress, Psychological, Coronavirus, Epidemics

Brief summary

The Coronavirus has a major influence on stress for the general population. However, data are currently non-existent concerning the perception and knowledge of the epidemic, the feeling of information from companies / establishments / governments, the means of protection used, the feelings of fear generated and their impact on feelings of stigmatization towards certain ethnic groups or categories of patients (those who cough ...), or relationships with socio-demographic factors or lifestyle.

Detailed description

This is an observational study using a REDCap® questionnaire via an internet link, which will be distributed by any means (Facebook, Twitter, institution mailing lists via a referent, flash codes distributed to patients and the public, etc.). The self-questionnaire will assess stress, perception and knowledge of the epidemic, the feeling of information on the part of businesses / establishments / governments, the means of protection used the feelings of fear generated and their impact on feelings of stigmatization towards certain ethnic groups or categories of patients (those who cough ...), or relationships with socio-demographic factors or lifestyle.

Interventions

None listed

Sponsors

UMR CNRS 6024 LaPSCo, Clermont-Ferrand, France
CollaboratorUNKNOWN
Wittyfit, Paris, France
CollaboratorUNKNOWN
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Anyone volunteer to participate

Exclusion criteria

* Anyone non-voluntary to participate

Design outcomes

Primary

MeasureTime frameDescription
StressDay 1Stress level will be assessed by questionnaire

Secondary

MeasureTime frameDescription
Perception and knowledge of the epidemicDay 1Perception and knowledge of the epidemic will be assessed by questionnaire
Feeling of information on the part of companies / establishments / governmentsDay 1The feeling of information will be assessed by questionnaire
Means of protectionDay 1the means of protection used will be assessed by questionnaire
Feelings of fear generated and its impact on feelings of stigmatization towards ethnic groups or categories of patientsDay 1The feeling of fear and the impact on stigmatization will be assessed by questionnaire
Sociodemographic factors and lifestyle habitsDay 1Sociodemographic factors and lifestyle habits will be assessed by questionnaire

Countries

France

Contacts

Primary ContactLise Laclautre
promo_interne_drci@chu-clermontferrand.fr0473754963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026